Loading...
XSTO
CRADb
Market cap112mUSD
Dec 05, Last price  
32.35SEK
1D
3.52%
1Q
1.09%
Jan 2017
168.46%
IPO
69.37%
Name

C Rad AB

Chart & Performance

D1W1MN
XSTO:CRADb chart
P/E
18.66
P/S
2.25
EPS
1.73
Div Yield, %
Shrs. gr., 5y
1.80%
Rev. gr., 5y
17.96%
Revenues
469m
+10.45%
1,291,1244,898,74914,234,44614,909,75525,775,90545,036,18453,191,61366,160,75182,653,556133,125,000190,110,000205,394,000221,628,000261,152,000301,326,000424,615,000469,004,000
Net income
56m
+58.88%
-10,722,785-10,250,579-9,838,118-42,606,182-19,388,657-20,994,730-6,298,477-21,183,842-31,209,176-10,907,00021,191,000-13,800,00014,365,00025,102,0007,479,00035,529,00056,448,000
CFO
30m
-9.91%
-10,055,732-8,726,049-5,014,115-20,426,509-13,063,389-22,856,329-16,611,834-22,951,019-44,623,107-4,020,000-9,606,00015,827,00018,447,00018,168,0009,690,00033,383,00030,076,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

C-Rad AB (publ), together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. The company operates through two segments, Positioning and Imaging. Its products include Sentinel 4D CT, a laser-based optical surface scanning system; Catalyst, a 4D surface image guided radiation therapy (SIGRT) solution; Catalyst HD, an SIGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst+, an SIGRT solution for high precision patient positioning, intra-fraction motion management, and respiratory gating; and Catalyst+ HD, a solution for high precision patient positioning, intra-fraction motion management, and respiratory gating for conventional and stereotactic treatment delivery. The company's products also comprise Catalyst Tomo, an enhanced positioning solution for tomotherapy; Catalyst PT, a real-time tracking solution for particle therapy; Cyrpa laser positioning products; cAccessory, which automates the registration and validation of treatment accessories; and cPatient that automates patient identity validation without the need for contact between patients and devices. In addition, it offers installation, application training, and aftersales services. C-Rad AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.
IPO date
Jul 23, 2007
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT